Cargando…
Long-Acting Injectable Statins—Is It Time for a Paradigm Shift?
In recent years, advances in pharmaceutical processing technologies have resulted in development of medicines that provide therapeutic pharmacokinetic exposure for a period ranging from weeks to months following a single parenteral administration. Benefits for adherence, dose and patient satisfactio...
Autores principales: | Tatham, Lee M., Liptrott, Neill J., Rannard, Steve P., Owen, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695729/ https://www.ncbi.nlm.nih.gov/pubmed/31344834 http://dx.doi.org/10.3390/molecules24152685 |
Ejemplares similares
-
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
por: Bakshi, Rahul P., et al.
Publicado: (2018) -
Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations
por: Curley, Paul, et al.
Publicado: (2023) -
Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants
por: Shakil, Anika, et al.
Publicado: (2022) -
Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems
por: Liptrott, Neill J., et al.
Publicado: (2018) -
Functional gastrointestinal disorders in inflammatory bowel disease: Time for a paradigm shift?
por: Vasant, Dipesh H, et al.
Publicado: (2020)